Abstract: We previously reported that miR-183 was downregulated during the direct conversion of dental pulp cells to insulin-producing cells. To further elucidate the role of miRNA regulation in dental pulp cells during this process, we examined the eff ect of miR-183 inhibition. Insulin expression was detected in induced cells 72 hours after ectopic expression of miR-183 inhibitor. The expression levels of insulin 1 and insulin 2 mRNA increased 1.7-fold and 1.6-fold, respectively. Insulin copy number estimates, following miR-183 inhibition, showed more than 10 copies each of insulin 1 and insulin 2. These data suggest that miR-183 downregulation induces the direct conversion of dental pulp cells to insulinproducing cells.
Introduction
Dental pulp-derived cells can differentiate into osteogenic, neurogenic, myogenic, and adipogenic lineage cells by applying in vitro induction conditions similar to those used for human bone marrow cells [1] [2] [3] [4] [5] . Notably, demethylation by 5-azacytidine triggers myogenic diff erentiation, suggesting that epigenetic modifi cation is involved in lineage diff erentiation in dental pulp cells 5) . Several pluripotent stem cell markers have been identifi ed, including Nanog, Sox2, and Oct3/4 (also known as Pou5f1) 6, 7) . Induced pluripotent stem (iPS) cells are produced by transfecting four genes, including Sox2 and Oct3/4, into fibroblasts 8) . Stem cell markers such as STRO-1, SSEA-1, Nanog, and Oct3/4 are expressed at low levels in dental pulp-derived cells, and downregulation of these markers is observed during lineage diff erentiation 1) . Previously, we reported that dental pulp cells can be directly converted to insulin-producing cells 9) . In vitro induction was performed using conditions similar to those reported for the differentiation of undifferentiated intestinal cells into endocrine progenitor cells [10] [11] [12] . Following the ectopic expression of defi ned transcription factors, the direct conversion of cells to endocrine lineage cells was induced, and insulin-producing cells were detected. Using microRNA array profi ling, some miRNAs were found to have significantly different expression patterns after 10 days of induction 9) . Notably, after induction, cellular miR-183 levels decreased by approximately 60%. To further elucidate the role of miR-183 in the direct conversion of dental pulp cells into insulin-producing cells, miR-183 was inhibited, and the extent of miRNA regulation evaluated.
Materials and Methods

Cell culture
Five-week old male Wistar rats were used in this study (Shimizu Laboratory Supply Co, Kyoto, Japan). Primary cultures were performed as previously described 4) . Briefly, approaching from the central side of the mandible, incisor dental pulp tissue was gently separated away from the distal site of the molars to excise the apical bud, using reamers (25 mm #10; Morita Co, Osaka, Japan). The tissue was then minced and incubated in phosphate-buffered saline (PBS) containing 3 mg/ ml type I collagenase (Invitrogen, Carlsbad, CA, USA) and 4 mg/ml dispase (Invitrogen) for 50 min at 37°C. The cells were cultured in MFstart basic medium (Toyobo Co, Osaka, Japan) supplemented with 10% (v/v) fetal calf serum (Invitrogen) at 37°C in a humidifi ed atmosphere containing 5% CO 2 . Animal experiments were performed in accordance with the Osaka Dental University guidelines for the care and use of laboratory animals.
Induction assay
Ambion anti-miR miRNA inhibitors (Thermo Fisher Scientific, Waltham, MA, USA) are chemically modifi ed, single stranded nucleic acids designed to specifi cally bind to and inhibit endogenous miRNA molecules. Anti-miR miRNA inhibitors enable functional miRNA analysis by downregulating miRNA activity. miR-183 inhibitor (50 nM) was transfected into the cells 2 days after inoculation. A mock study was also performed using 50 nM Cy3 dye-labeled antimiR negative controls (Thermo Fisher Scientific, Tokyo, Japan). Transfections were performed using the FuGENE HD transfection reagent (Roche Diagnostics, Indianapolis, IN, USA) in accordance with the manufacturer's instructions. The medium was replaced with basic medium 1 day after each transfection. Subsequently, the expression of markers was examined to evaluate the eff ects of diff erentiation in the cells.
Immunostaining
After fi xation with 4% (w/v) paraformaldehyde, cells were treated with 0.1 M phosphate buffer containing 0.1% Triton X-100, washed with 10 mM glycine in PBS and incubated in 3% (w/v) BSA in PBS for 30 minutes at room temperature (20-25°C) to block nonspecific reactions. After washing with 10 mM glycine in PBS, the cells were incubated with an appropriately diluted primary antibody for 1 hour at room temperature, washed with 0.1% BSA in PBS, and incubated for 1 hour at room temperature with a fl uorescently labeled secondary antibody. An anti-Insulin guinea pig antibody (1:200; Abcam, Cambridge, UK) was used as the primary antibody, and Alexa 488-conjugated goat anti-guinea pig (1:1000; Molecular Probes, Eugene, Oregon, USA) was used as the secondary antibody. The samples were then washed with 0.1% BSA in PBS, counterstained with 4', 6-diamidino-2-phenylindole (Invitrogen) and mounted in Permafl uor (Immunotech, Marseille, France). Immunofluorescence signals were observed by fluorescence microscopy, using a BZ-9000 microscope (Keyence Co, Osaka, Japan).
RNA extraction
Total RNA was isolated from the cells by acid guanidinium thiocyanate-phenol-chloroform extraction with Isogen in accordance with the manufacturer's instructions (Nippon Gene Co Ltd, Tokyo, Japan). Cells were homogenized in Isogen (5 × 10 6 cells/ml of Isogen) followed by extraction with 200μl of chloroform. After a second extraction using 650μl of chloroform and precipitation with 1 ml of isopropanol, the precipitated RNA was washed in 1 ml of 70% ethanol. All centrifugation was done at 12,000 × g at 4°C. The RNA obtained was dissolved in UltraPure DNase/RNase-free distilled water (Life Technologies, Carsburg, CA, USA), and its concentration was measured by NanoDrop (Thermo Fisher Scientifi c) at 260 nm.
Quantitative real-time RT-PCR assay
cDNAs were synthesized from total RNA using a High Capacity cDNA Reverse Transcription kit (Applied Biosystems, Foster City, CA, USA) in accordance with the manufacturer's instructions. As a reference to allow comparison between samples, 1.0 × 10 8 copies of λpolyA+ RNA-A (Takara Bio Inc, Kusatsu, Shiga, Japan) were added per 1 μg of total RNA during the cDNA synthesis process. Real-time RT-PCR was performed using the Fast SYBR Green PCR Master Mix (Applied Biosystems) to examine the expression levels of each marker. Specifi c PCR primer sets for Insulin 1 (Ins1) and Insulin 2 (Ins 2) were designed using the Perfect Real Time Support System (Takara Bio Inc.). PCR amplification was performed using the StepOne Plus system (Applied Biosystems) with an initial denaturation step of 20 sec at 95°C, followed by 40 cycles each of 95°C for 3 sec and 60°C for 30 sec, concluding with an automatic melting curve stage. The expression levels are presented as the fold-change values after induction compared with those before induction and were calculated using the ∆∆Ct 13) . Differences between values were statistically analyzed by the Mann-Whitney U test using SPSS software (https://www.ibm.com/ analytics/us/en/technology/spss/).
Estimation of expressed copy number
A quantitative standard curve was created using diluted λpolyA+ RNA-A. Diluted samples (10 -2 , 10 -3 , 10 -4 , 10 -5 , and 10 -6 ) for 5.0 × 10 6 copies were prepared using the EASY Dilution for Real Time PCR kit (Takara Bio Inc.) and the Real Time primer for λpolyA (Takara Bio Inc.) was used for quantitative real-time RT-PCR.
Results
Detection of insulin in dental pulp cells by inhibition of miR-183
Insulin production was not observed at 72 hours after mock transfection with Cy3 anti-miR negative controls (Fig. 1A) . In contrast, insulin production was observed 72 hours after transfection of the miR-183 inhibitor (Fig. 1B) .
Induction of insulin mRNA expression by inhibition of miR-183
Ectopic expression of miR-183 inhibitor induces insulin at 72 hours after induction. Ins2 is the murine homologue of the human insulin gene and is located on mouse chromosome 7. Ins1, which is thought to have evolved by a gene duplication event, lacks the second intron of the Ins2 gene, is located on mouse chromosome 19. Qualitative expression analysis showed that Ins1 and Ins2 expression signifi cantly increased after miR-183 inhibition by 1.7-fold and 1.6-fold, respectively, (p < 0.05) (Fig. 2) .
Ins1 and Ins2 copy number induced by inhibition of miR-183
The Ct mean value was dependent on the serial dilution of λpolyA+ RNA-A. The 10 ( Fig. 3) . λpolyA+ RNA-A was added as an external reference during the reverse transcription process. The Ct value means of Ins1 and Ins2 were 33.7 and 33.3, respectively, and were plotted on the standard curve. Using the standard curve, the copy number estimates for Ins1 and Ins2 were 12.9 and 16.2, respectively; thus, slightly more than 10 copies were present after miR-183 inhibition.
Discussion Highly effi cient miRNA-mediated reprogramming of somatic cells has previously been reported 14, 15) . The expression of the miR302b/367 or miR302/miR-372 cluster rapidly and effi ciently reprograms somatic cells to iPS cells without exogenous transcription factors such as Oct3/4 or Sox2. Therefore, we hypothesized that cells derived from the dental pulp can be regulated by miRNAs through the process of direct reprogramming. Previously, we comprehensively analyzed changes in miRNA levels during the direct conversion of dental pulp cells into insulin-producing cells by LNA array and reported eight candidate regulatory miRNAs. Notably, 10 days after induction by ectopic expression of the defi ned transcription factors, miR-183 levels were less than 40% of those observed pre-induction 9) . To further evaluate the role of miRNAs during this process in dental pulp cells, we inhibited miR-183 in the cells. We found that inhibition of miR-183 induced insulin expression in dental pulp cells, while no change was observed in mocktransfected cells. These results suggest that the direct conversion of dental pulp cells into the cells of developmentally unrelated tissues involves miRNA-dependent regulation. Recently, some reports show that miR-183 is detectable in human serum, urine, and in exosome vesicles from human sera and is involved in endocrine-associated signal transduction [16] [17] [18] . Given that miRNAs, including miR-183, work as a cluster, it remains unclear whether miR-183 is the only major miRNA involved in this process. Nevertheless, our results show that at least one miRNA, a functional small non-coding RNA, contributes to the direct conversion of cells from one lineage to another. Future directions should focus on elucidating the identity and role of other miRNAs in this process.
The present study has enlarged the potential cell sources suitable for regenerative medicine. Indeed, factors secreted by dental pulp stem cells have been identifi ed to have multifaceted therapeutic benefi ts for recovery after several types of injuries or diseases, such as those of the spinal cord, heart, and liver [19] [20] [21] . Therefore, pluripotent cells derived from oral tissue are an attractive and promising tool in the fi eld of tissue regeneration and engineering. This study demonstrated that more than approximately 10 copies of insulin mRNA were involved in inducing dental pulp cells. We believe that dental pulp cells, or factors secreted by dental pulp cells, will become an acceptable source of cells for cell therapy in the future, replacing the more controversial sources currently used.
